CANNAPHARMARX, INC. Cash Flow Statement
CPMD|11 years of annual SEC 10-K data (FY2014-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 11 fiscal years. All figures from audited SEC 10-K filings.
CANNAPHARMARX, INC. used $789,102 in operating cash flow and negative free cash flow of $794,621 in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -18.28 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$11.1M | -$9.9M | -$8.5M | -$8.8M | -$19.9M | -$20.5M | -$3.1M | -$6.6K | -$1.0M | -$11.7M | -$4.0M |
| Depreciation & Amortization | - | $0 | $294.9K | $2.7K | $128.5K | $129.0K | $0 | - | - | - | $0 |
| Operating Cash Flow | -$789.1K | -$1.7M | -$1.4M | -$2.4M | -$563.6K | -$3.8M | -$941.1K | $0 | -$22.4K | -$2.5M | -$1.5M |
| Capital Expenditures | $5.5K | $0 | - | - | - | $4.8K | $0 | - | $0 | $2.1K | $100.7K |
| Free Cash Flow | -$794.6K | -$1.7M | - | - | - | -$3.8M | -$941.1K | - | -$22.4K | -$2.6M | -$1.6M |
| Share Buybacks | - | - | - | - | $0 | $99.0K | $0 | - | - | $350.0K | - |
| FCF Margin | -58.3% | -206.9% | - | - | - | - | - | - | - | - | - |